HRP20080417T5 - Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it - Google Patents

Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
HRP20080417T5
HRP20080417T5 HR20080417T HRP20080417T HRP20080417T5 HR P20080417 T5 HRP20080417 T5 HR P20080417T5 HR 20080417 T HR20080417 T HR 20080417T HR P20080417 T HRP20080417 T HR P20080417T HR P20080417 T5 HRP20080417 T5 HR P20080417T5
Authority
HR
Croatia
Prior art keywords
expressed
crystalline form
ivabradine
chlorohydrate
preparation
Prior art date
Application number
HR20080417T
Other languages
English (en)
Croatian (hr)
Inventor
Horvath St�phane
Auguste Marie-No�lle
Damien G�rard
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20080417T3 publication Critical patent/HRP20080417T3/xx
Publication of HRP20080417T5 publication Critical patent/HRP20080417T5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
HR20080417T 2005-02-28 2008-08-27 Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it HRP20080417T5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501990A FR2882556B1 (fr) 2005-02-28 2005-02-28 Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
HRP20080417T3 HRP20080417T3 (en) 2008-09-30
HRP20080417T5 true HRP20080417T5 (en) 2008-11-30

Family

ID=34954879

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080417T HRP20080417T5 (en) 2005-02-28 2008-08-27 Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it

Country Status (43)

Country Link
US (3) US7361651B2 (zh)
EP (1) EP1695709B1 (zh)
JP (1) JP4628975B2 (zh)
KR (1) KR100827503B1 (zh)
CN (1) CN100432057C (zh)
AP (1) AP2112A (zh)
AR (1) AR056931A1 (zh)
AT (1) ATE397933T1 (zh)
AU (1) AU2006200855B2 (zh)
BR (1) BRPI0600696A (zh)
CA (1) CA2537404C (zh)
CO (1) CO5770095A1 (zh)
CR (1) CR8246A (zh)
CU (1) CU23615B7 (zh)
CY (1) CY1108220T1 (zh)
DE (1) DE602006001411D1 (zh)
DK (1) DK1695709T3 (zh)
EA (1) EA008532B1 (zh)
EC (1) ECSP066376A (zh)
ES (1) ES2308688T3 (zh)
FR (1) FR2882556B1 (zh)
GE (1) GEP20084468B (zh)
GT (1) GT200600086A (zh)
HK (1) HK1096660A1 (zh)
HR (1) HRP20080417T5 (zh)
IL (1) IL173960A0 (zh)
MA (1) MA28132A1 (zh)
ME (2) ME02750B (zh)
MY (1) MY157933A (zh)
NO (1) NO338482B1 (zh)
NZ (1) NZ545579A (zh)
PE (1) PE20061070A1 (zh)
PL (1) PL1695709T3 (zh)
PT (1) PT1695709E (zh)
RS (1) RS50600B (zh)
SA (1) SA06270041B1 (zh)
SG (1) SG125233A1 (zh)
SI (1) SI1695709T1 (zh)
TW (1) TWI314142B (zh)
UA (1) UA81340C2 (zh)
UY (1) UY29407A1 (zh)
WO (1) WO2006092494A1 (zh)
ZA (1) ZA200601760B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
EP2097383B1 (en) 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101353325B (zh) * 2007-07-27 2011-11-09 上海优拓医药科技有限公司 稳定型盐酸伊伐布雷定结晶及其制备方法
US8212026B2 (en) 2007-05-30 2012-07-03 Ind-Swift Laboratories Limited Process for the preparation of ivabradine hydrochloride and polymorph thereof
WO2010072409A1 (en) 2008-12-22 2010-07-01 Krka, D. D., Novo Mesto Process for preparation of ivabradine
CN101774969B (zh) 2009-01-13 2012-07-04 江苏恒瑞医药股份有限公司 硫酸伊伐布雷定及其i型结晶的制备方法
EP2902384B1 (en) 2010-02-12 2017-11-08 KRKA, D.D., Novo Mesto Form of ivabradine hydrochloride
HUP1000245A2 (en) 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
WO2012025940A1 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Polymorphic form of ivabradine hydrochloride and process for preparation thereof
EP2726462B1 (en) * 2011-08-02 2017-03-22 Sandoz AG Acetone solvate of ivabradine hydrochloride
WO2013064427A1 (en) 2011-11-04 2013-05-10 Synthon Bv A process for making crystalline delta-form of ivabradine hydrochloride
EP2589594A1 (en) 2011-11-04 2013-05-08 Urquima S.A. Ivabradine hydrochloride Form IV
US9120755B2 (en) 2011-11-14 2015-09-01 Cadila Healthcare Limited Polymorphic forms of ivabradine hydrochloride
WO2014114341A1 (en) 2013-01-24 2014-07-31 Synthon Bv Process for making ivabradine
CZ305096B6 (cs) 2013-10-02 2015-04-29 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
ES2672472T3 (es) 2013-12-12 2018-06-14 Synthon Bv Composición farmacéutica que comprende ivabradina amorfa
EP2774606B1 (en) 2014-02-14 2019-01-30 Synthon B.V. Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
CZ305436B6 (cs) 2014-07-10 2015-09-16 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Ｆｓｂｍ重組蛋白及其用途
TR201703066A2 (tr) 2017-02-28 2018-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
IT202000025312A1 (it) 2020-10-26 2022-04-26 Cambrex Profarmaco Milano S R L Processi per la preparazione di polimorfi di ivabradina hcl

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US534859A (en) * 1895-02-26 Condenser for ice-machines
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0547151B1 (en) 1990-08-29 2002-11-20 Humanetics Corporation Treatment process for promoting weight loss employing a substituted delta 5-androstene
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2818552B1 (fr) 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) * 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
NO20060949L (no) 2006-08-29
MY157933A (en) 2016-08-15
TWI314142B (en) 2009-09-01
AR056931A1 (es) 2007-11-07
GEP20084468B (en) 2008-08-25
FR2882556A1 (fr) 2006-09-01
TW200640871A (en) 2006-12-01
CU20060038A7 (es) 2008-06-30
DK1695709T3 (da) 2008-09-29
WO2006092494A1 (fr) 2006-09-08
EA200600323A1 (ru) 2006-08-25
SI1695709T1 (sl) 2008-10-31
FR2882556B1 (fr) 2007-05-04
CN100432057C (zh) 2008-11-12
AU2006200855B2 (en) 2010-12-23
MA28132A1 (fr) 2006-09-01
PL1695709T3 (pl) 2008-10-31
CY1108220T1 (el) 2014-02-12
EA008532B1 (ru) 2007-06-29
GT200600086A (es) 2006-11-02
US20090318420A1 (en) 2009-12-24
ECSP066376A (es) 2006-11-16
CR8246A (es) 2008-01-21
JP4628975B2 (ja) 2011-02-09
NO338482B1 (no) 2016-08-22
CA2537404C (fr) 2010-04-13
AU2006200855A1 (en) 2006-09-14
KR20060095503A (ko) 2006-08-31
ME01394B (me) 2013-12-20
ZA200601760B (en) 2008-04-30
AP2112A (en) 2010-03-03
IL173960A0 (en) 2006-07-05
EP1695709A1 (fr) 2006-08-30
ES2308688T3 (es) 2008-12-01
KR100827503B1 (ko) 2008-05-06
UA81340C2 (en) 2007-12-25
CU23615B7 (es) 2011-01-27
PT1695709E (pt) 2008-07-04
US20060194964A1 (en) 2006-08-31
SG125233A1 (en) 2006-09-29
DE602006001411D1 (de) 2008-07-24
PE20061070A1 (es) 2006-11-18
CA2537404A1 (fr) 2006-08-28
EP1695709B1 (fr) 2008-06-11
HRP20080417T3 (en) 2008-09-30
CO5770095A1 (es) 2007-06-29
HK1096660A1 (zh) 2007-06-08
ME02750B (me) 2010-05-07
RS50600B (sr) 2010-05-07
SA06270041B1 (ar) 2010-03-08
JP2006241157A (ja) 2006-09-14
US20080153804A1 (en) 2008-06-26
ATE397933T1 (de) 2008-07-15
BRPI0600696A (pt) 2007-05-08
UY29407A1 (es) 2006-07-31
US7872001B2 (en) 2011-01-18
US7361651B2 (en) 2008-04-22
AP2006003522A0 (en) 2006-02-28
CN1827601A (zh) 2006-09-06
NZ545579A (en) 2007-01-26

Similar Documents

Publication Publication Date Title
HRP20080417T5 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
HRP20080418T5 (en) Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
HRP20080406T5 (en) Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
HRP20080520T3 (en) Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
AR056573A1 (es) Forma cristalina delta del clohidrato de ivabradina,un procedimiento para su preparacion,composiciones farmaceuticas que la contienen y usos en trastornos cardiovasculares.
AR056572A1 (es) FORMA CRISTALINA ð DEL CLOHIDRATO DE IVABRADINA,UN PROCEDIMIENTO PARA SU PREPARACION,COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN Y USOS EN TRASTORNOS CARDIOVASCULARES.
JO3360B1 (ar) الشكل البلوري الجديد 3 للأغوميلاتين وعملية تحضيره والمكونات الصيدلانية التي تحتويه
BRPI0603043A (pt) forma cristalina iv de agomelatina, um processo para sua preparação e composições farmacêuticas contendo-a
TW200736199A (en) New crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TNSN07164A1 (en) Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
HK1109767A1 (en) Quaternary ammonium salts as m3 antagonists
JP2008500392A5 (zh)
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
MX2009006018A (es) Derivados de quinuclidinol como antagonistas de receptores muscarinicos.
MXPA05005340A (es) Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
TH81392B (th) รูปแบบผลึก y ของอิวาบราดีน ไฮโดรคลอไรด์ กระบวนการสำหรับการเตรียมของสารนั้นและสารผสมทางยาซึ่งมีสารนั้น
TH81392A (zh)
TH81391B (th) รูปแบบผลึก Bd ของ อิวาบราดีน ไฮโดรคลอไรด์ กระบวนการสำหรับการเตรียมของสารนั้นและสารผสมทางยาซึ่งมีสารนั้น
TH81391A (zh)
TH89977A (th) รูปฟอร์มผลึก เดลตาd ของไอวาบราดีน ไฮโดรคลอไรด์, กระบวนการสำหรับการจัดเตรียมสารนั้นและองค์ประกอบในทางเภสัชกรรมที่มีสารนั้น
TH89976B (th) รูปฟอร์มผลึก เดลตา ของไอวาบราดีน ไฮโดรคลอไรด์, กระบวนการสำหรับการจัดเตรียมสารนั้นและสารผสมในทางเภสัชกรรมที่มีสารนั้น
JO2501B1 (en) The crystalline form of gamma-D of ivabradine hydrochloride, its preparation process and its pharmaceutical ingredients